• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Intertek banner
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

Extrafine particles and the potential for enhanced inhaled drug delivery: A Q&A with Chiesi’s Dave Lewis

When we studied the effect of BAM pressure on dose delivery, we found that increasing BAM pressure, improved dispersion performance, increasing the fraction of particles in in the sub-5 µm range, as shown in the table below. The incorporation of a BAM results in release of the powder into a relatively high air flow rate, so dispersion is a more energetic process, as well as being closely controlled. The results from our investigations suggest that use of a BAM not only enhances the success of aerosolization but improves its consistency, giving more constant drug delivery performance across different inhalation profiles independently from the applied flow rate.

Table 1: FSI dispersion performance from the 4 DPI variants; mean values (n=3)

  No BAM  Low BAM  Control BAM  High BAM 
Shot weight (mg)  9.7 ± 1.0 9.2 ± 0.1 10.0 ± 0.6 9.1 ± 0.3
Metered dose (µg)  423 ± 11 410 ± 4 443 ± 10 407 ± 33
Fine particle dose <5µm (µg)  129 ± 2 158 ± 9 187 ± 9 222 ± 18
Fine particle fraction <5µm (%)  31 ± 1 39 ± 2 42 ± 2 54 ± 2

Exerting tighter control over the dispersion process, via technology such as this, would seem to be a sensible direction of travel if we want to push aerosolization performance into new areas, using the same energy input, which is essentially the challenge.

 

Share
« Previous Page 1 2 3 4 5 6

published on January 31, 2017

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Proveris_180x150a
    © 2025 OINDPnews